entrestohcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-Agent: * Disallow: Sitemap: | ||
Meta Tags
| Title | ENTRESTO® (sacubitril/valsartan) | HCP |
| Description | Learn more about ENTRESTO, access valuable HCP resources, and review clinical trial information. See full prescribing & safety info, including BOXED |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 45.60.13.232 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
entrestohcp.com Valuation
|
US$76,602,927
Last updated: 2023-05-08 09:10:51
entrestohcp.com has Semrush global rank of 138,171. entrestohcp.com has an estimated worth of US$ 76,602,927, based on its estimated Ads revenue. entrestohcp.com receives approximately 8,838,800 unique visitors each day. Its web server is located in United States, with IP address 45.60.13.232. According to SiteAdvisor, entrestohcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$76,602,927 |
| Daily Ads Revenue | US$70,711 |
| Monthly Ads Revenue | US$2,121,312 |
| Yearly Ads Revenue | US$25,455,742 |
| Daily Unique Visitors | 589,254 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| entrestohcp.com. | A | 86399 | IP: 45.60.13.232 |
| entrestohcp.com. | A | 86399 | IP: 45.60.19.232 |
| entrestohcp.com. | NS | 1800 | NS Record: dns1.novartis.com. |
| entrestohcp.com. | NS | 1800 | NS Record: a1-254.akam.net. |
| entrestohcp.com. | NS | 1800 | NS Record: a24-65.akam.net. |
| entrestohcp.com. | NS | 1800 | NS Record: dns2.novartis.com. |
| entrestohcp.com. | NS | 1800 | NS Record: dns4.novartis.com. |
| entrestohcp.com. | NS | 1800 | NS Record: a7-64.akam.net. |
| entrestohcp.com. | NS | 1800 | NS Record: a9-65.akam.net. |
| entrestohcp.com. | NS | 1800 | NS Record: a2-66.akam.net. |
| entrestohcp.com. | NS | 1800 | NS Record: dns3.novartis.com. |
| entrestohcp.com. | NS | 1800 | NS Record: a28-67.akam.net. |
| entrestohcp.com. | TXT | 86400 | TXT Record: dd29ed34-4a9d-42de-ae7f-e366df2fbe23 |
| entrestohcp.com. | TXT | 86400 | TXT Record: 1c03f250q5sfmn6jj5b13b1sxfpn9f8s |
| entrestohcp.com. | TXT | 86400 | TXT Record: google-site-verification=OJpUrzQP4SotjYBMLBQxNZiJxLlCQs_TxJ-r-ScrggU |
HtmlToTextCheckTime:2023-05-08 09:10:51
| X For US Health Care Professionals Only Full Prescribing Information Patient Website Contact Sales Support Share For US Health Care Professionals Only 2022 Heart Failure Guideline HFrEF ACC ECDP Update Clinical & Biomarker Data Cardiac Remodeling Quality of Life Hospitalization & Initiation HFpEF with LVEF below normal* Safety & Dosing Safety Dosing Support & Resources CONTACT A SALES SPECIALIST --> * In PARAGON-HF, defined as LVEF ≥45% with structural heart disease (LAE or LVH); median LVEF was 57%. LVEF is a variable measure and the normal range can vary. 1 Reference: 1. ENTRESTO [prescribing information]. East Hanover, NJ: Novartis Pharmaceuticals Corp. 2022 AHA/ACC/HFSA HF GUIDELINE recognizes ENTRESTO ® in three HF patient populations 1 † See the latest guidance > --> 2022 AHA/ACC/HFSA HF GUIDELINE recognizes ENTRESTO ® in three HF patient populations 1 † See the latest guidance. > Choose ENTRESTO ® for a broad range of patients with heart failure 2 Results |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Location: https://www.entrestohcp.com/
Content-Length: 0
Connection: close
HTTP/1.1 200 OK
Date: Fri, 29 Oct 2021 18:27:04 GMT
X-Frame-Options: DENY
X-XSS-Protection: 1; mode=block
X-Content-Type-Options: nosniff
Content-Type: text/html; charset=ISO-8859-1
Strict-Transport-Security: max-age=63072000; includeSubdomains; preload
Set-Cookie: JSESSIONID=1uHNTis3AvfyQasYGX0FVQ8mPj7y71ZBKNM4Rp15frqzwSxj3RP5!-398582094; path=/; secure; HttpOnly
Content-Language: en-US
Vary: User-Agent
Set-Cookie: TS0131734b=01f27bbbb1d76909eafbe143a90953c325bb528e7fd8786b4d8e2a927ac7c56fa22fb038a67bb016c058be3aa95ad07c97675e87532420558926155c1f5996c5768cef7d05; Path=/; Domain=.www.entrestohcp.com; Secure; HTTPOnly
Transfer-Encoding: chunked
Set-Cookie: visid_incap_2378014=pYYzIBspQV2Woo5zb4ZyEfc8fGEAAAAAQUIPAAAAAADSCf385qIjfFJ82V2F3Ghb; expires=Sat, 29 Oct 2022 09:01:50 GMT; HttpOnly; path=/; Domain=.entrestohcp.com
Set-Cookie: incap_ses_1003_2378014=3xziJAAYajh1vkMBpF/rDfg8fGEAAAAAVgJ+gg2A8/Ssx/AWdnmHLA==; path=/; Domain=.entrestohcp.com
Set-Cookie: ___utmvmvMuMYmYZ=TZfaDpOqxVb; path=/; Max-Age=900
Set-Cookie: ___utmvavMuMYmYZ=PFAMhVo; path=/; Max-Age=900
Set-Cookie: ___utmvbvMuMYmYZ=dZe
XulOsalM: rtR; path=/; Max-Age=900
X-CDN: Imperva
X-Iinfo: 11-10183006-10183010 NNNN CT(95 195 0) RT(1635532023692 31) q(0 0 3 2) r(4 4) U6
|
entrestohcp.com Whois Information
Domain Name: ENTRESTOHCP.COM Registry Domain ID: 1926500972_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-04-05T09:04:36Z Creation Date: 2015-05-07T15:34:58Z Registry Expiry Date: 2023-05-07T15:34:58Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: A1-254.AKAM.NET Name Server: A2-66.AKAM.NET Name Server: A24-65.AKAM.NET Name Server: A28-67.AKAM.NET Name Server: A7-64.AKAM.NET Name Server: A9-65.AKAM.NET Name Server: DNS1.NOVARTIS.COM Name Server: DNS2.NOVARTIS.COM Name Server: DNS3.NOVARTIS.COM Name Server: DNS4.NOVARTIS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-17T06:51:19Z <<< |